Author

Tate Mckinnon-Snell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alexandrine CarminatiiD· 1 shared Anandita Mathur· 1 shared Avinash GuptaiD· 1 shared Brian Ritchie DavidsoniD· 1 shared Charlotte ButtercaseiD· 1 shared Erik A. SahaiiD· 1 shared Gareth J. PriceiD· 1 shared Ginevra Pistocchi· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexandrine CarminatiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Splenic granulopoiesis and S100A9 drive resistance to checkpoint inhibitors conferred by liver metastases

Rebecca J. Lee, Steven Hooper, Laura J. Pallett, Mariana O. Diniz, Tate Mckinnon-Snell, Zoe Ramsden, Nicolas Rabas, Stefan Boeing, Oliver John Kennedy, Charlotte Buttercase, Gloryanne Aidoo-Micah, Gareth J. Price, Sarah C. Macfarlane, Sasha Bailey, Jessica E. Davies, , Erik A. Sahai

This study shows liver metastases reduce checkpoint inhibitor efficacy by increasing splenic granulopoiesis and S100A9hi neutrophils, which suppress T-cell responses, and demonstrates that targeting S100A9 restores efficacy.

bioRxiv · Sep 30, 2025 · PreprintImmunology